Integrative Genomic Profiling Of Rcc Treated With Second-Line Nivolumab

JOURNAL OF CLINICAL ONCOLOGY(2020)

引用 0|浏览55
暂无评分
摘要
720Background: Clear cell renal cell carcinoma (ccRCC) is the most common subtype of kidney cancer comprising up to 80% of RCC. Anti-vascular endothelial growth factor receptor (VEGFR) is a common ...
更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要